Christina P. C. Borba

Christina P. C. Borba

Auto-generated profile, based on publicly available information

Christina P. C. Borba

Department of Psychiatry, Boston University School of Medicine, Boston, MA, United States

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2008 in Annals of Behavioral Medicine
Verified
Journal Article
Closed access
PDF file
JPJulia E. Painter
Julia E. Painter
CBChristina P. C. Borba
Christina P. C. Borba
MHMichelle Hynes
Michelle Hynes
DMDarren Mays
Darren Mays
Karen GlanzKaren Glanz
Karen Glanz
Theory-based health behavior change programs are thought to be more effective than those that do not use theory. No previous reviews have assessed the extent to which theory is used (that is, operationalized and tested) in empirical research. The purpose of this study was to describe theory use in recent health behavior literature and to assess the proportion of research that uses theory along a continuum from: informed by theory to applying, testing, or building theory. A sample of empirical research articles (n = 193) published in ten leading public health, medicine, and psychology journals from 2000 to 2005 was coded to determine whether and how theory was used. Of health behavior articles in the sample, 35.7% mentioned theory. The most-often-used theories were The Transtheoretical Model, Social Cognitive Theory, and Health Belief Model. Most theory use (68.1%) involved research that was informed by theory; 18% applied theory; 3.6% tested theory; and 9.4% sought to build theory. About one third of published health behavior research uses theory and a small proportion of those studies rigorously apply theory. Patterns of theory use are similar to reports from the mid-1990s. Behavioral researchers should strive to use theory more thoroughly by applying, testing, and building theories in order to move the field forward.

1 January 2005 in Archives of General Psychiatry
Verified
Journal Article
Open access
PDF file
DHDavid C. Henderson
David C. Henderson
ECEnrico Cagliero
Enrico Cagliero
PCPaul M. Copeland
Paul M. Copeland
CBChristina P. Borba
Christina P. Borba
AEAnne Eden Evins
Anne Eden Evins
DGDonald C. Goff
Donald C. Goff
Compared with the general population, life expectancy in patients with schizophrenia is shorter by as much as 20%, attributable to higher rates of suicide, accidental deaths, and natural causes such as cardiovascular disease, infectious disease, and endocrine disorders.1,2 Recently, the newer “atypical” antipsychotic agents have been linked to several forms of morbidity, including obesity; hyperlipidemia; type 2 diabetes mellitus; and diabetic ketoacidosis.3-5 While impaired glucose metabolism has been frequently reported, the mechanisms responsible for such an association remain unclear, as does the relative risk for individual atypical antipsychotic agents.

8 February 2012 in Harvard Review of Psychiatry
Verified
Journal Article
Open access
GFGregory L. Fricchione
Gregory L. Fricchione
CBChristina P. C. Borba
Christina P. C. Borba
AAAtalay Alem
Atalay Alem
TSTeshome Shibre
Teshome Shibre
JCJulia R. Carney
Julia R. Carney
DHDavid C. Henderson
David C. Henderson
We suggest that the optimal approach to building capacity in global mental health care will require partnerships between professional resources in high-income countries and promising health-related institutions in low- and middle-income countries. The result of these partnerships will be sustainable academic relationships that can educate a new generation of in-country primary care physicians and, eventually, specialized health professionals. Research capabilities will be an essential educational component to inform policy and practice, and to ensure careful outcome measurements of training and of intervention, prevention, and promotion strategies. The goal of these academic centers of excellence will be to develop quality, in-country clinical and research professionals, and to build a productive environment for these professionals to advance their careers locally. In sum, this article discusses human capacity building in global mental health, provides recommendations for training, and offers examples of recent initiatives.

1 May 2006 in Annals of Clinical Psychiatry
Verified
Journal Article
Closed access
DHDavid C. Henderson
David C. Henderson
CBChristina P. Borba
Christina P. Borba
TDTara B. Daley
Tara B. Daley
RBRyan Boxill
Ryan Boxill
DNDana D. Nguyen
Dana D. Nguyen
DGDonald C. Goff
Donald C. Goff
The increasing prevalence of overweight and obesity has become a priority public health issue in the United States. Forty to 62% of people with schizophrenia are obese or overweight (1, 2). High morbidity and mortality in schizophrenia may be attributed to an unhealthy lifestyle such as poor diet, lack of exercise, smoking, and substance abuse (3). Obesity is associated with greater risk of developing hypertension, type 2 diabetes, coronary heart disease, stroke, death, and reduced quality of life compared with that found in the general population (4, 5). We performed a cross-sectional study evaluating the dietary intake of patients with schizophrenia or schizoaffective disorder treated with atypical antipsychotic agents. Dietary intake of 88 patients from an urban community mental health clinic was measured using a four-day dietary record. Nutritional variables included total energy intake, fat, protein, carbohydrate, cholesterol, fiber, sucrose, folate, calcium, sodium, zinc, alcohol and caffeine. Data were compared to the general population using data matched for age, gender, and ethnicity from the National Health and Nutrition Examination Survey (NHANES), 1999-2000. The Body Mass Index (BMI) of the schizophrenia group (M = 31.3, SD = 12.67) was significantly greater than the NHANES group (M = 28.3, SD = 6.62) (p = .001). The schizophrenia group consumed significantly fewer calories, carbohydrate, protein, total fat, saturated fat, monounsaturated fatty acid (MUFA), polyunsaturated fatty acid (PUFA), fiber, folate, sodium and alcohol and significantly more caffeine than the NHANES group. The findings may suggest that obesity in schizophrenia patients is not solely related to food consumption, but perhaps other effects including medication side effects and reduced physical activity. Education and interventions for the schizophrenia population should focus more on overall lifestyle factors such as physical activity and healthy food choices.

1 May 2005 in American Journal of Psychiatry
Verified
Journal Article
Closed access
DHDavid C. Henderson
David C. Henderson
PCPaul M. Copeland
Paul M. Copeland
TDTara B. Daley
Tara B. Daley
CBChristina P. Borba
Christina P. Borba
CCCorrine Cather
Corrine Cather
DGDonald C. Goff
Donald C. Goff

24 August 2005 in Acta Psychiatrica Scandinavica
Verified
Journal Article
Closed access
PDF file
DHD. C. Henderson
D. C. Henderson
LKL. Kunkel
L. Kunkel
DND. D. Nguyen
D. D. Nguyen
CBC. P. Borba
C. P. Borba
TDT. B. Daley
T. B. Daley
DGD. C. Goff
D. C. Goff